Clinical Study Results
Where can I learn more about this study?
More information about this study is available on the website listed below.
- www.AstraZenecaClinicalTrials.com. Once you are on the website, type "D5740C00003" into the search box, and click "Find a Study".
Full Trial Title: An Open-label, Randomized, Cross-over, Single-center Study to Compare Single-dose Pharmacokinetic and Pharmacodynamic Characteristics of US-marketed (Epogen®) and Two European-marketed Epoetin Alfas (Eprex® and Binocrit®) in Healthy Subjects
AstraZeneca Protocol Number: D5740C00003
AstraZeneca AB sponsored this study and has its headquarters in Södertälje, Sweden.
The phone number for the AstraZeneca Information Center is +1 877 240 9479.
Thank you!
Clinical study participants belong to a large community of people who take part in clinical research around the world. They help researchers answer important health questions and find medical treatments for participants.
The Center for Information & Study on Clinical Research Participation (CISCRP) is a non-profit organization focused on educating and informing the public about clinical research participation. CISCRP is not involved in recruiting participants for clinical studies, nor is it involved in conducting clinical studies.
CISCRP
One Liberty Square, Suite 1100 • Boston, MA 02109
1-877-MED-HERO • www.ciscrp.org
Version 1.0 2019_08_30 8